AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2021
Jan 8, 2021
35460_dirs_2021-01-08_488f041d-03f4-4c2f-9da9-a3c6d488cbcb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2020-12-30
Reporting Person: Wilkins Robert G. (Chief Medical Officer)
More from Enveric Biosciences, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 18